Literature DB >> 16891319

Neuronal atrophy and synaptic alteration in a mouse model of dentatorubral-pallidoluysian atrophy.

Kenji Sakai1, Mitsunori Yamada, Toshiya Sato, Masahito Yamada, Shoji Tsuji, Hitoshi Takahashi.   

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is a hereditary spinocerebellar degeneration caused by expansion of a CAG repeat in the disease protein. Despite the restricted and stable brain lesions, DRPLA patients show a variety of clinical symptoms and the brain exhibits generalized atrophy. In previous studies of DRPLA, we proposed that intranuclear diffuse accumulation of the mutant protein is a significant pathological feature of neurons, and that the variable prevalence of this pathology may be relevant to the variation of symptoms observed in patients with different repeat sizes. In this study, to elucidate the pathogenesis of the brain atrophy in DRPLA, we conducted morphological and statistical analyses of neurons affected by the polyglutamine pathology in DRPLA transgenic (Tg) mice with 129 polyglutamine stretches. Golgi-impregnated pyramidal neurons in cerebral cortical layer V of 15-week-old Tg mice showed significant atrophy of the perikarya and dendrites. Dendritic spines were decreased in number and size, and showed a change in morphology resulting in dominance of stubby spines. Interestingly, dendritic arborization was preserved. Electron microscopy revealed that axons in the pyramis and corpus callosum were also atrophic. The number of axonal microtubules was preserved; however, the inter-microtubule spacing was significantly decreased. In the neuropil of cerebral cortical layers II and III, atrophy of the pre-synaptic areas and lengths of the post-synaptic density was detected, but synaptic vesicle diameter was preserved. These results suggest that neuronal atrophy is an essential feature of the cell pathology in DRPLA and that this is closely related to polyglutamine pathogenesis and development of the clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891319     DOI: 10.1093/brain/awl182

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  7 in total

1.  Radiologic and neuropathologic findings in patients in a family with dentatorubral-pallidoluysian atrophy.

Authors:  Y Sunami; R Koide; N Arai; M Yamada; T Mizutani; K Oyanagi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

Review 2.  Polyglutamine expansion in Drosophila: thermal stress and Hsp70 as selective agents.

Authors:  Brian R Bettencourt; Catherine C Hogan; Mario Nimali
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

Review 3.  What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Authors:  Jasmine Donaldson; Sophie Powell; Nadia Rickards; Peter Holmans; Lesley Jones
Journal:  J Huntingtons Dis       Date:  2021

Review 4.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

5.  MicroRNA function is required for neurite outgrowth of mature neurons in the mouse postnatal cerebral cortex.

Authors:  Janet Hong; Haijun Zhang; Yoko Kawase-Koga; Tao Sun
Journal:  Front Cell Neurosci       Date:  2013-09-13       Impact factor: 5.505

Review 6.  Pallidal degenerations and related disorders: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-08-07       Impact factor: 3.850

7.  Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice.

Authors:  Toshiya Sato; Masami Miura; Mitsunori Yamada; Takayuki Yoshida; Jonathan D Wood; Ikuru Yazawa; Masao Masuda; Takeo Suzuki; Ryong-Moon Shin; Hau-Jie Yau; Fu-Chin Liu; Takayoshi Shimohata; Osamu Onodera; Christopher A Ross; Motoya Katsuki; Hitoshi Takahashi; Masanobu Kano; Toshihiko Aosaki; Shoji Tsuji
Journal:  Hum Mol Genet       Date:  2008-11-27       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.